Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Pharmaceuticals & Biotechnology | Small Cap
Health Score : 5.90Tarsons Products Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation. However, its liquidity and efficiency ratios reveal areas needing attention. While revenue growth is positive, declines in operating profit, EPS, asset growth, and net income raise concerns about sustainable growth. The company's interest coverage is strong, but its dividend coverage is weak. Overall, Tarsons shows promising profitability but faces challenges in efficiency and consistent growth. The healthcare industry's specific dynamics, such as regulatory changes and market competition, may influence these financial metrics. The company's future performance will depend on addressing these challenges and capitalizing on its strengths.
Health Score : 5.90Tarsons Products Ltd, operating in the Healthcare Services sector, demonstrates a mixed financial performance. The company shows strong solvency and profitability, indicating a solid foundation. However, its liquidity and efficiency ratios reveal areas needing attention. While revenue growth is positive, declines in operating profit, EPS, asset growth, and net income raise concerns about sustainable growth. The company's interest coverage is strong, but its dividend coverage is weak. Overall, Tarsons shows promising profitability but faces challenges in efficiency and consistent growth. The healthcare industry's specific dynamics, such as regulatory changes and market competition, may influence these financial metrics. The company's future performance will depend on addressing these challenges and capitalizing on its strengths.
Overall Valuation Score
Markets Depth NSE
Buy Orders
Bid
Quantity
Orders
No buy depth
Total
0
0
Sell Orders
Ask
Quantity
Orders
No sell depth
Total
0
0
Markets Today NSE
High
0.00
Low
0.00
Open
0.00
Close
0.00
Prev Close
0.00
Avg Price
0.00
Volume
0
Last Traded Quantity
0
Last Traded Time
N/A
Price Movement Indicator
Today's Low: 0.00
Today's High: 0.00
P/E RATIO (TTM)
80.77
Industry Median
47.24
Small Cap Median
47.24
P/E RATIO
127.92
P/B RATIO
2.89
Industry Median
2.89
Small Cap Median
2.89
P/S RATIO
4.33
Industry Median
4.33
Small Cap Median
4.33
Others
PEG RATIO
-3.89
EV/EBITDA RATIO
14.26
The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹344.1 as on Sep 1, 2026.
Growth Score : 4.00Tarsons Products Ltd. shows a mixed growth performance. While the Revenue Growth Rate is positive, indicating increasing sales, the declines in Operating Profit Growth Rate, Earnings Per Share (EPS) Growth, Asset Growth Rate, and Net Income Growth Rate raise concerns about sustainability. The weighted average calculation offers a balanced view of these trends, emphasizing the need for improvements in profitability and operational efficiency to support future growth.
Revenue Growth RateExcellentOperating Profit Growth RatePoorEarnings Per Share (EPS) GrowthPoorAsset Growth RatePoorNet Income Growth RatePoor| Growth Ratios | Mar 2022 | Mar 2025 | Mar 2026 |
|---|---|---|---|
| Revenue Growth Rate | 31.44 | 32.43 | 7.91 |
| Operating Profit Growth Rate | 48.54 | 11 | 6.31 |
| Earnings Per Share (EPS) Growth | -99.47 | -30.09 | -51.96 |
| Asset Growth Rate | 83.78 | 11.11 | 9.81 |
| Net Income Growth Rate | 46.38 | -30.23 | -53.33 |
Revenue Growth Rate
Operating Profit Growth Rate
Earnings Per Share (EPS) Growth
Asset Growth Rate
Net Income Growth Rate
Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.
| NO | Company Name | Health Score | P/E Ratio | Valuation | OPM | EPS | Latest Profit & Loss |
|---|---|---|---|---|---|---|---|
| 1 | Aprameya Engineering Ltd | 7.25 | 47.24 | Neutral | 10.53 | 2.65 | 5.13 |
| 2 | Tarsons Products Ltd | 5.90 | 127.92 | Neutral | 118.00 | 4.26 | 14.00 |
0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI
Overall Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Market Sentiment
Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe
Trend Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Momentum Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Volatility Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Bullish
Volume Score
Strong Bearish
Bearish
Neutral
Bullish
Strong Bullish
Neutral
Analyzing moving average trends and crossovers. Green/Red badges indicate if the current condition passes or fails.
Comparing stock price performance (normalized) against benchmark indices over time.
Recent daily trading volume represented as a bar chart, alongside historical averages.
Current closing price relative to the 52-week highest and lowest prices.
Quarterly Report⬤6th Feb 26
Quarterly Financial Results Q3 FY 2025-26
NEUTRAL SENTIMENT
Tarsons Products Ltd is a leading Indian manufacturer of scientific plasticware, laboratory consumables, and instruments. Catering to research, healthcare, academic, and industrial sectors, it offers a diverse product portfolio including liquid handling, cell culture, and cryogenics. The company has a strong domestic and growing international market presence.
P/E Ratio (TTM): Price to Earnings ratio shows how much an investor pays for every rupee of the company's earnings. Tarsons Products Ltd's P/E ratio (TTM) is 80.77, compared to the industry median of 47.24 and large cap median of 47.24.
P/B Ratio: Price to Book ratio compares a company's market price to its book value per share. Tarsons Products Ltd's P/B ratio is 2.89, compared to the industry median of 2.89 and large cap median of 2.89.
P/S Ratio: Price to Sales ratio compares a company's market value to its total revenue. Tarsons Products Ltd's P/S ratio is 4.33, compared to the industry median of 4.33 and large cap median of 4.33.
PEG Ratio: PEG ratio adjusts the P/E ratio for expected earnings growth. Tarsons Products Ltd's PEG ratio is -3.89.
EV/EBITDA Ratio: This ratio compares a company's enterprise value to its earnings before interest, tax, depreciation, and amortization. Tarsons Products Ltd's EV/EBITDA ratio is 14.26.
Return on Equity (ROE): ROE measures how much profit a company generates from shareholders' invested capital. Tarsons Products Ltd's ROE is 2.20%.
Return on Assets (ROA): ROA measures how efficiently a company converts its assets into net profit. Tarsons Products Ltd's ROA is 9.95%.
Return on Capital Employed (ROCE): ROCE measures how efficiently a company generates profit from all the capital it employs. Tarsons Products Ltd's ROCE is 5%.
Operating Margin: Operating margin shows what percentage of revenue remains after covering operating expenses. Tarsons Products Ltd's operating margin is 27.90%.
Net Margin: Net margin shows what percentage of revenue converts into final net profit. Tarsons Products Ltd's net margin is 3.31%.
Current Ratio: The current ratio measures a company's ability to pay short-term liabilities using short-term assets. Tarsons Products Ltd's current ratio is 0.89.
Debt to Equity Ratio: This ratio shows the proportion of debt a company uses relative to shareholders' equity. Tarsons Products Ltd's debt-to-equity ratio is 0.35.
Interest Coverage Ratio: This ratio shows how easily a company can pay interest on its outstanding debt from its operating earnings. Tarsons Products Ltd's interest coverage ratio is 1.96.
Dividend Per Share (DPS): DPS shows the total dividend paid per share in the latest financial year. Tarsons Products Ltd's DPS is ₹0.
Earnings Per Share (EPS): EPS shows how much profit is allocated to each outstanding share. Tarsons Products Ltd's EPS is -51.96.
(Source line: "Ratios as of 23 Oct 2026, based on last traded price of ₹344.10. Data sourced from BSE/NSE Exchange Filings & Public Terminal Data.")
Founded: 1983
Headquarters: Kolkata, West Bengal
Core Offerings: Pipettes & Pipettors, Centrifuge Ware, Cryogenics, Liquid Handling, Cell Culture Products
Stock Listing: NSE (TARSONS), BSE (543399)
Promoter: Lohia family
Founded in 1983 by Mr. Sanjoy Lohia to manufacture high-quality plastic labware, Tarsons Products Ltd expanded its portfolio and manufacturing capabilities over the decades. It established a strong distribution network both domestically and internationally. The company successfully completed an Initial Public Offering (IPO) in November 2021, listing on NSE and BSE to fund expansion and working capital needs, maintaining its focus on R&D and product innovation.
| Segment Name | Revenue % | EBITDA |
|---|---|---|
| Manufacturing and Trading of Laboratory Plasticware & Scientific Products | 100% | Operating Profit |
Laboratory Plasticware & Scientific Products: Tarsons designs, manufactures, and markets an extensive range of high-quality laboratory plasticware, consumables, and instruments crucial for scientific research, diagnostics, and industrial applications.
Diverse Product Portfolio: Key offerings span liquid handling systems (pipettes), cell culture products, cryogenic storage solutions, centrifugation ware, and general labware, serving multiple segments of the life sciences and healthcare industries.
Integrated Operations: The company manages its operations from conceptualization and R&D to manufacturing in state-of-the-art facilities in West Bengal, supported by a robust pan-India and expanding global distribution network.
Mr. Sanjoy Lohia (Chairman & Managing Director): A visionary entrepreneur with over four decades of experience in the laboratory consumables industry, he founded Tarsons Products Ltd and has been instrumental in its growth and success. Mr. Rohan Lohia (Whole-time Director & CEO): Son of Mr. Sanjoy Lohia, he brings leadership and strategic direction to the company's operations, focusing on business expansion and technological advancements.
No major subsidiaries reported.
Initial Public Offering (IPO) in November 2021. 1:1 Bonus Issue declared in September 2023.
The Tarsons Products Ltd share price today is ₹344.10 on NSE (TARSONS), as of 24 Oct 2026.
As of 23 Oct 2026, Tarsons Products Ltd share price is ₹344.10, with previous close ₹344.10. Today's range is ₹344.10 to ₹344.10. The 52-week range is ₹164.45 to ₹375.
As of today, Tarsons Products Ltd's market cap is ₹1,830.61 crore (Small Cap).
Tarsons Products Ltd's current P/E ratio is 80.77, compared to the HEALTHCARE EQUIPMENT & SUPPLIES sector average of 48.
Tarsons Products Ltd's current P/B ratio is 2.89.
Tarsons Products Ltd's current dividend yield is N/A. Last dividend of ₹2.00 per share was declared on 18-Aug-2023.
Tarsons Products Ltd's EPS (TTM) is ₹-51.96.
Tarsons Products Ltd is a leading Indian manufacturer of scientific plasticware, laboratory consumables, and instruments. Catering to research, healthcare, academic, and industrial sectors, it offers a diverse product portfolio including liquid handling, cell culture, and cryogenics. The company has a strong domestic and growing international market presence.
Tarsons Products Ltd is promoted by Lohia family, holding 47.3% as of 23 Oct 2026.
Tarsons Products Ltd is listed on NSE (TARSONS) and BSE (543399). Its next quarterly results are expected on August 2024 (Q1 FY25).
Adjusted Earnings Per Share (Adjusted EPS)
